Rate My Professor Simon Jakobovits

Simon Jakobovits is an Adjunct Senior Lecturer in Gastroenterology at Monash University. He is a Melbourne-based gastroenterologist with a special interest in inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis. In addition to his focus on IBD, he investigates and treats general gastroenterological complaints. Jakobovits earned his Bachelor of Medicine and Bachelor of Surgery from Monash University in 1998. He completed his physician training at The Alfred Hospital in Melbourne, followed by specialist gastroenterology training at Western Hospital, Footscray Hospital, and St Vincent’s Hospital, Melbourne. He enhanced his expertise with a research and clinical fellowship in inflammatory bowel diseases at the John Radcliffe Hospital in Oxford, United Kingdom. His career encompasses both clinical practice and academic contributions, reflecting a commitment to advancing patient care and medical education in gastroenterology.

In clinical practice, Simon Jakobovits serves as a visiting specialist at The Alfred Hospital and maintains a private gastroenterology practice at Cabrini Medical Centre in Malvern. He provides endoscopy services at various centres in Melbourne’s western suburbs, such as Hobson’s Bay Endoscopy Centre in Altona and Northwest Endoscopy Centre in Ascot Vale. Dedicated to teaching the next generation of healthcare professionals, he instructs medical students from Monash University Medical School at The Alfred Hospital and Cabrini Hospital. He holds the position of Honorary Senior Lecturer at Monash University and Lecturer at Latrobe University. Jakobovits has contributed to research in IBD management, with key publications including “Anti-TNF therapeutic drug monitoring in postoperative Crohn's disease” (Journal of Crohn's and Colitis, 2018), “Entyvio lengthen dose-interval study: Lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease” (European Journal of Gastroenterology & Hepatology, 2018), “Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - A POCER study analysis” (Alimentary Pharmacology & Therapeutics, 2015), and “Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery” (Gastroenterology, 2015).